Skip to main content

Wockhardt has received final approval from the US FDA for marketing 5mg/5ml of oxycodone HCI liquid. The company is launching the product soon and will be amongst the few generic versions of this product in the market.

[adsense:336x280:8701650588]

Oxycodone is used extensively in management of pain, especially in opioid tolerant patients. Wockhardt already markets several other controlled substance products in the US and generally has a leading presence in the liquid formulations segment.  In the US generic pharma market, Wockhardt has been consistently growing market shares for all its products.


<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>